1374 related articles for article (PubMed ID: 23726868)
1. Hydrogen sulfide slows down progression of experimental Alzheimer's disease by targeting multiple pathophysiological mechanisms.
Giuliani D; Ottani A; Zaffe D; Galantucci M; Strinati F; Lodi R; Guarini S
Neurobiol Learn Mem; 2013 Sep; 104():82-91. PubMed ID: 23726868
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of Hydrogen Sulfide against the Progression of Severe Alzheimer's Disease in Transgenic Mice at Different Ages.
Vandini E; Ottani A; Zaffe D; Calevro A; Canalini F; Cavallini GM; Rossi R; Guarini S; Giuliani D
Pharmacology; 2019; 103(1-2):50-60. PubMed ID: 30448835
[TBL] [Abstract][Full Text] [Related]
3. Melanocortins protect against progression of Alzheimer's disease in triple-transgenic mice by targeting multiple pathophysiological pathways.
Giuliani D; Bitto A; Galantucci M; Zaffe D; Ottani A; Irrera N; Neri L; Cavallini GM; Altavilla D; Botticelli AR; Squadrito F; Guarini S
Neurobiol Aging; 2014 Mar; 35(3):537-47. PubMed ID: 24094579
[TBL] [Abstract][Full Text] [Related]
4. Hydrogen sulfide improves spatial memory impairment and decreases production of Aβ in APP/PS1 transgenic mice.
He XL; Yan N; Zhang H; Qi YW; Zhu LJ; Liu MJ; Yan Y
Neurochem Int; 2014 Feb; 67():1-8. PubMed ID: 24412510
[TBL] [Abstract][Full Text] [Related]
5. Hydrogen sulfide ameliorates learning memory impairment in APP/PS1 transgenic mice: A novel mechanism mediated by the activation of Nrf2.
Liu Y; Deng Y; Liu H; Yin C; Li X; Gong Q
Pharmacol Biochem Behav; 2016; 150-151():207-216. PubMed ID: 27883916
[TBL] [Abstract][Full Text] [Related]
6. Dipotassium N-stearoyltyrosinate ameliorated pathological injuries in triple-transgenic mouse model of Alzheimer's disease.
Liu S; Tang SQ; Cui HJ; Yin S; Yin M; Zhao H; Meng LH; Wang ZJ; Lu Y
J Pharmacol Sci; 2016 Sep; 132(1):92-99. PubMed ID: 27671351
[TBL] [Abstract][Full Text] [Related]
7. Hydrogen sulfide attenuates spatial memory impairment and hippocampal neuroinflammation in β-amyloid rat model of Alzheimer's disease.
Xuan A; Long D; Li J; Ji W; Zhang M; Hong L; Liu J
J Neuroinflammation; 2012 Aug; 9():202. PubMed ID: 22898621
[TBL] [Abstract][Full Text] [Related]
8. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
[TBL] [Abstract][Full Text] [Related]
9. Hydrogen sulfide down-regulates BACE1 and PS1 via activating PI3K/Akt pathway in the brain of APP/PS1 transgenic mouse.
He XL; Yan N; Chen XS; Qi YW; Yan Y; Cai Z
Pharmacol Rep; 2016 Oct; 68(5):975-82. PubMed ID: 27372924
[TBL] [Abstract][Full Text] [Related]
10. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
Clausen A; Xu X; Bi X; Baudry M
J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
[TBL] [Abstract][Full Text] [Related]
11. CART modulates beta-amyloid metabolism-associated enzymes and attenuates memory deficits in APP/PS1 mice.
Yin K; Jin J; Zhu X; Yu L; Wang S; Qian L; Han L; Xu Y
Neurol Res; 2017 Oct; 39(10):885-894. PubMed ID: 28743230
[TBL] [Abstract][Full Text] [Related]
12. Hydrogen sulfide protects amyloid-β induced cell toxicity in microglia.
Liu YY; Bian JS
J Alzheimers Dis; 2010; 22(4):1189-200. PubMed ID: 20930302
[TBL] [Abstract][Full Text] [Related]
13. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
McClean PL; Hölscher C
Neuropharmacology; 2014 Jan; 76 Pt A():57-67. PubMed ID: 23973293
[TBL] [Abstract][Full Text] [Related]
14. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
[TBL] [Abstract][Full Text] [Related]
15. Hydrogen sulfide reduces mRNA and protein levels of β-site amyloid precursor protein cleaving enzyme 1 in PC12 cells.
Zhang H; Gao Y; Zhao F; Dai Z; Meng T; Tu S; Yan Y
Neurochem Int; 2011 Feb; 58(2):169-75. PubMed ID: 21095213
[TBL] [Abstract][Full Text] [Related]
16. Imipramine, in part through tumor necrosis factor alpha inhibition, prevents cognitive decline and beta-amyloid accumulation in a mouse model of Alzheimer's disease.
Chavant F; Deguil J; Pain S; Ingrand I; Milin S; Fauconneau B; Pérault-Pochat MC; Lafay-Chebassier C
J Pharmacol Exp Ther; 2010 Feb; 332(2):505-14. PubMed ID: 19889791
[TBL] [Abstract][Full Text] [Related]
17. Protocatechuic acid improves cognitive deficits and attenuates amyloid deposits, inflammatory response in aged AβPP/PS1 double transgenic mice.
Song Y; Cui T; Xie N; Zhang X; Qian Z; Liu J
Int Immunopharmacol; 2014 May; 20(1):276-81. PubMed ID: 24667368
[TBL] [Abstract][Full Text] [Related]
18. Effect of huprine X on β-amyloid, synaptophysin and α7 neuronal nicotinic acetylcholine receptors in the brain of 3xTg-AD and APPswe transgenic mice.
Hedberg MM; Clos MV; Ratia M; Gonzalez D; Lithner CU; Camps P; Muñoz-Torrero D; Badia A; Giménez-Llort L; Nordberg A
Neurodegener Dis; 2010; 7(6):379-88. PubMed ID: 20689242
[TBL] [Abstract][Full Text] [Related]
19. Fibrillar Amyloid-β Accumulation Triggers an Inflammatory Mechanism Leading to Hyperphosphorylation of the Carboxyl-Terminal End of Tau Polypeptide in the Hippocampal Formation of the 3×Tg-AD Transgenic Mouse.
Ontiveros-Torres MÁ; Labra-Barrios ML; Díaz-Cintra S; Aguilar-Vázquez AR; Moreno-Campuzano S; Flores-Rodríguez P; Luna-Herrera C; Mena R; Perry G; Florán-Garduño B; Luna-Muñoz J; Luna-Arias JP
J Alzheimers Dis; 2016 Mar; 52(1):243-69. PubMed ID: 27031470
[TBL] [Abstract][Full Text] [Related]
20. Nobiletin, a citrus flavonoid, improves cognitive impairment and reduces soluble Aβ levels in a triple transgenic mouse model of Alzheimer's disease (3XTg-AD).
Nakajima A; Aoyama Y; Shin EJ; Nam Y; Kim HC; Nagai T; Yokosuka A; Mimaki Y; Yokoi T; Ohizumi Y; Yamada K
Behav Brain Res; 2015 Aug; 289():69-77. PubMed ID: 25913833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]